T. Rowe Price Associates’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Hold |
0
| – | -$2.45M | – | 3002 |
|
|
2022
Q4 | – | Hold |
0
| – | -$2.61M | – | 1392 |
|
|
2022
Q3 | – | Sell |
-125,242
| Closed | -$4.04M | – | 1354 |
|
|
2022
Q2 | $4.04M | Sell |
125,242
-1,554
| -1% | -$50.1K | ﹤0.01% | 1446 |
|
|
2022
Q1 | $5.17M | Sell |
126,796
-7,127
| -5% | -$291K | ﹤0.01% | 1460 |
|
|
2021
Q4 | $5.96M | Buy |
133,923
+5,871
| +5% | +$261K | ﹤0.01% | 1474 |
|
|
2021
Q3 | $6.37M | Sell |
128,052
-123
| -0.1% | -$6.12K | ﹤0.01% | 1480 |
|
|
2021
Q2 | $6.86M | Sell |
128,175
-11,330
| -8% | -$606K | ﹤0.01% | 1459 |
|
|
2021
Q1 | $6.37M | Buy |
139,505
+1,264
| +0.9% | +$57.7K | ﹤0.01% | 1440 |
|
|
2020
Q4 | $6.72M | Sell |
138,241
-103,433
| -43% | -$5.03M | ﹤0.01% | 1400 |
|
|
2020
Q3 | $10.7M | Sell |
241,674
-55,095
| -19% | -$2.43M | ﹤0.01% | 1286 |
|
|
2020
Q2 | $11.5M | Sell |
296,769
-581,066
| -66% | -$22.4M | ﹤0.01% | 1266 |
|
|
2020
Q1 | $36.2M | Buy |
+877,835
| New | +$36.2M | 0.01% | 893 |
|